Who Paid My Doc
Blenrep
Biological Oncology
NDC 0173-0896-01
General payments
$3,960,033
Research payments
$9,046,674
Through program year 2025, $3,960,033 in general payments and $9,046,674 in research payments were reported against Blenrep (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $83,387 | 2,667 |
| 2024 | General | $7,646 | 12 |
| 2023 | General | $7,503 | 21 |
| 2023 | Research | $131,673 | 32 |
| 2022 | General | $1,779,851 | 5,592 |
| 2022 | Research | $5,044,220 | 47 |
| 2021 | General | $1,543,590 | 4,907 |
| 2021 | Research | $3,870,781 | 59 |
| 2020 | General | $538,056 | 1,239 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 51 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 47 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
14,438 general · 138 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.